LifeGoal Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$331K Sell
5,305
-313
-6% -$19.8K 0.1% 125
2026
Q2
$324K Sell
5,618
-1,206
-18% -$69.3K 0.15% 93
2026
Q1
$421K Buy
+6,824
New +$398K 0.24% 61

Other funds holding BMY

LifeGoal Wealth Advisors's BMY Position: Q3 2026 in Review

LifeGoal Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q3 2026, selling an estimated $19.8K and leaving 5,305 shares worth $331K. The position accounts for 0.1% of the portfolio, ranked #125.

LifeGoal Wealth Advisors first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. The position peaked at $421K in Q1 2026. 129 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • LifeGoal Wealth Advisors held 5,305 shares of Bristol-Myers Squibb worth $331K as of Q3 2026.
  • LifeGoal Wealth Advisors sold 313 Bristol-Myers Squibb shares in Q3 2026, an estimated $19.8K.
  • Bristol-Myers Squibb made up 0.1% of LifeGoal Wealth Advisors's portfolio in Q3 2026, its #125 holding.
  • LifeGoal Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • LifeGoal Wealth Advisors's Bristol-Myers Squibb position peaked at $421K in Q1 2026.
  • 129 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on LifeGoal Wealth Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.